An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Pancreatic cancer in adults: diagnosis and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Feb. (NICE Guideline, No. 85.)
Top results in this bookTable of Contents
Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2011 Apr. (NICE Clinical Guidelines, No. 122.)
Genetic Susceptibility to Breast and Ovarian Cancer: Assessment, Counseling and Testing Guidelines.
Bethesda (MD): American College of Medical Genetics; 1999.
Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low Resource Settings.
Geneva: World Health Organization; 2012.
Guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus.
Geneva: World Health Organization; 2018.
Screening for Ovarian Cancer: An Updated Evidence Review for the U.S. Preventive Services Task Force [Internet].
Henderson JT, Webber EM, Sawaya GF.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Feb. (Evidence Synthesis, No. 157.)
Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation.
Geneva: World Health Organization; 2011.
Collaborative Framework for Care and Control of Tuberculosis and Diabetes.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy.
Geneva: World Health Organization; 2013.
Combination Use of Insulin and Incretins in Type 2 Diabetes [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Jul. (CADTH Optimal Use Report, No. 3.1C.)
Optimal Use Recommendations for Second- and Third-Line Therapy for Patients With Type 2 Diabetes [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Jul. (CADTH Optimal Use Report, No. 3.1D.)
Diabetic Foot Infections [Internet].
Mills JP, Patel P, Broekhuizen E, et al.
Ann Arbor (MI): Michigan Medicine University of Michigan; 2019 Oct.
CADTH Canadian Drug Expert Committee Recommendation: Lixisenatide (Adlyxine — Sanofi-aventis Canada Inc.): Indication: Diabetes mellitus, type 2 [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Nov.
CADTH Canadian Drug Expert Committee Recommendation: Insulin Degludec (Tresiba — Novo Nordisk Canada Inc.): Indication: Diabetes Mellitus, Types I and II [Internet].
CADTH Canadian Drug Expert Committee Final Recommendation: Canagliflozin and Metformin Hydrochloride: (Invokamet — Janssen Inc.): Indication: Type 2 Diabetes Mellitus [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug.
CADTH Canadian Drug Expert Committee Final Recommendation: Dapagliflozin: (Forxiga — AstraZeneca Canada Inc.): Indication: Type 2 Diabetes [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 May.
CADTH Canadian Drug Expert Committee Recommendation: Insulin Glargine and Lixisenatide (Soliqua — Sanofi-Aventis Canada Inc.): Indication: Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin (less than 60 units daily) alone or in combination with metformin [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan 3.
CADTH Canadian Drug Expert Committee Recommendation: Dexamethasone (Ozurdex — Allergan Canada Inc.): Indication: For the treatment of adult patients with diabetic macular edema who are pseudophakic [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Hyperparathyroidism (primary): diagnosis, assessment and initial management.
London: National Institute for Health and Care Excellence (NICE); 2019 May 23. (NICE Guideline, No. 132.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on